Medcrypt helps you navigate RTA

Topics:
FDA readiness
This is some text inside of a div block.
Thought leadership
This is some text inside of a div block.
All authors
All authors

November 9, 2023

Medcrypt helps you navigate RTA

Introduction

In the fast-paced world of medical device innovation, ensuring the security and compliance of your products is paramount. On September 27, 2023, the FDA released the final guidance, “Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions.” This guidance demands rigorous attention to detail, cybersecurity readiness, and strategic planning. Medcrypt understands these challenges, and with our team of FDA and medical device experts, we’re here to guide you through the submission process seamlessly.

Our Services

At Medcrypt, we offer a comprehensive range of services to support your regulatory readiness:

1. FDA Cybersecurity Filing Readiness Survey:

A free assessment for MDMs to gauge submission readiness by responding to survey questions aligned with the new FDA guidance, including responding to survey questions aligned with the new FDA guidance, with eSTAR for 510(k)s and optionally for de novo submissions, and with other refusal types for filings not submitted via eSTAR.. This service provides valuable insights into the risks to acceptance for the submission.

2. FDA Cybersecurity Filing Remediation:

For MDMs who do not pass the FDA Filing Readiness Survey or face an FDA refusal (e.g., RTA, RTF, AINN, MAJR, NSE, NOAP), Medcrypt’s experts can help identify cybersecurity gaps and create a prioritized plan to rectify issues, ensuring the submission’s cybersecurity content becomes acceptable.

3. FDA Cybersecurity Submission Readiness:

Designed for MDMs with submissions either already under FDA review or planned for the near future, this service offers a comprehensive review using Medcrypt’s unique five-sector framework (review of threat modeling, post-market management, vulnerability management, security risk assessment, and SBOM processes and outcomes) to ensure cybersecurity compliance.

4. FDA Cybersecurity Hold Letter Response:

In the event of an FDA hold letter, Medcrypt provides immediate guidance to navigate the response process effectively.

Our Unique Approach

What sets Medcrypt apart is our unique approach to cybersecurity readiness. Our knowledge gained from past submissions ensures insights into FDA expectations that benefit all Medical Device Manufacturers. This means that our expertise is continuously refined and updated based on real-world challenges and solutions.

The Benefits of Choosing Medcrypt

  1. FDA Insights: With FDA leaders on our team, we offer unparalleled insights into the FDA’s expectations and requirements, ensuring your submission aligns with their standards.
  2. Customized Solutions: We understand that every medical device is unique. Our services are tailored to your specific needs and the intricacies of your product.
  3. Proven Expertise: Medcrypt’s track record in the industry speaks for itself. We’ve successfully guided numerous companies through the FDA submission process and helped them achieve compliance.
  4. Comprehensive Support: From initial submission preparation to ongoing cybersecurity program development, we provide end-to-end support to safeguard your products.

Conclusion

Navigating the FDA submission process doesn’t have to be a daunting task. With Medcrypt’s experienced team by your side, you can streamline your submission preparation, prioritize cybersecurity remediation, and achieve program maturity. Our unique approach, coupled with a deep understanding of FDA expectations, ensures your medical devices are compliant and secure in an ever-evolving threat landscape. Trust Medcrypt to be your partner in achieving FDA cybersecurity readiness and ensuring the safety of your innovations.

Don’t know where to start? Start by taking our complimentary FDA Cybersecurity Filing Readiness Survey.

Related articles

Understanding the Impact of the Pause in NVD Vulnerability Analysis and Exploring New Solutions
This is some text inside of a div block.

Understanding the Impact of the Pause in NVD Vulnerability Analysis and Exploring New Solutions

Tools & processes
This is some text inside of a div block.
Vulnerability management
This is some text inside of a div block.
MedISAO
MedISAO

May 29, 2024

Medical Device Cybersecurity - 2023 Learnings and 2024 Expectations
This is some text inside of a div block.

Medical Device Cybersecurity - 2023 Learnings and 2024 Expectations

All topics
This is some text inside of a div block.
Axel Wirth
Axel Wirth

December 18, 2023

Subscribe to Medcrypt news

Get the latest healthcare cybersecurity news right in your inbox.

We'll never spam you or sell your information

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.